Please login to the form below

Not currently logged in
Email:
Password:

Biotest makes two senior management appointments

Promotion for Jörg Schüttrumpf while Markus Rothenburger joins from Fresenius Kabi

Markus Rothenburger, Biotest Biotest has promoted Dr Jörg Schüttrumpf to head its global research efforts, while Professor Markus Rothenburger (pictured) will join the company as head of medical/regulatory affairs.

Dr Schüttrumpf only joined the Germany-based biopharma in July 2012, and will now have responsibility for early research and development in Biotest's key areas of focus: immunology, haematology and intensive care.

His career prior to joining Biotest includes positions at Essen und Frankfurt am Main university hospitals as well as at the blood donor service DRK-Blutspendedienst Baden-Württemberg-Hessen.

“He is the ideal candidate to head this important area,” said Biotest's chair Professor Gregor Schulz.

“Dr Schüttrumpf is a specialist in the fields of coagulation research and transfusion medicine, and was therefore our first choice for this position.'

Prof Rothenburger joins Biotest from his role as VP medical and clinical affairs at Fresenius Kabi.

He has also served at Novartis, and has clinical experience in vascular and heart surgery during his time working in hospital.

“We win an excellent medical specialist and a pharmaceutical manager with wide-ranging industry connections,” said Prof Schulz .

19th December 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics